)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Carasent
Carasent (CARA) investor relations material
Carasent Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary15 Oct, 2026
Executive summary
Q3 revenue rose 32% YoY to SEK 108.2m, with 12% organic growth; organic ARR growth was 14%.
Adjusted EBITDAC reached SEK 21.4m at a 20% margin, up from 15%; Nordic strength and Infosolutions supported growth while German weakness weighed on results.
Contracted ARR reached SEK 424m, up 29% YoY; recurring revenue exceeded 90%, with 3% churn and 110% net revenue retention.
Financial highlights
Subscription revenue grew 26% to SEK 84.4m, transaction revenue 36% to SEK 14.0m, and consulting and other revenue 106% to SEK 9.7m.
Gross profit increased 29% to SEK 90.8m; gross margin was 83.9% versus 85.4% YoY.
Reported EBITDA was SEK 27.5m, up 17%, with a 25% margin versus 29%; adjusted EBITDAC rose 75% to SEK 21.4m.
Jan-Sep revenue was SEK 296.3m; adjusted EBITDA was SEK 64.7m, including SEK 4.2m in non-recurring expenses.
Outlook and guidance
Q4 costs are expected to exceed Q3 as holiday-related cost reductions end and spending rises on German sales and marketing, Medsum MDR certification, and AI usage.
Germany sales activity is set to increase under a new CEO and expanded sales team; Webcur rollout and legacy-product modernization are planned.
Infosolutions price increases are planned around year-end; its profitability is in line with the broader business following integration measures.
Medsum rollout is planned to continue at a high pace; an AI-enabled Webdoc interface is scheduled to begin rolling out around year-end.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Carasent
- Q2 2026 saw 18% sales growth, margin expansion, and accelerated AI adoption.CARA
Q2 2026 - 16% ARR growth, 20% EBITDA margin, and 19% Nordics ARR boost amid German legacy churn.CARAQ1 2026
- Strong Q4 and 2025 growth, high margins, and strategic investments drive robust outlook.CARAQ4 2025
- Revenue up 26% and ARR up 27%, but profitability pressured by restructuring and AI costs.CARAQ2 2025
- €8m acquisition enables German EHR market entry, adding 1,000+ customers and growth potential.CARAM&A Announcement
- Revenue up 19% YoY, adjusted EBITDA margin 19%, strong cash flow despite one-time costs.CARAQ3 2024
- 15% recurring revenue growth, 16% EBITDA margin, and strong ARR backlog drive future growth.CARAQ2 2024
- 29% revenue growth and 16% EBITDA margin highlight strong operational progress.CARAQ1 2025
- Strong Q4 revenue and margin growth, with new deals set to drive further gains in 2025.CARAQ4 2024
Next Carasent earnings date
Q4 20264 Feb, 2027
Carasent
Next Carasent earnings date
Q4 20264 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Carasent ASA is a Norwegian investment management company that provides cloud-based software solutions to the healthcare industry in the Nordic region. The Company is an open platform for application developers, asset owners and its own portfolio of hospitals. Carasent has footprint within Norway, Sweden, Finland and Denmark. Carasent develops software for managing medical records in a digital manner. The company is based in Olso, Norway.